| Literature DB >> 34774105 |
Anouck Amestoy1,2,3, Etienne Guillaud4, Giulia Bucchioni4,5, Tiziana Zalla6, Daniel Umbricht7, Christopher Chatham7, Lorraine Murtagh7, Josselin Houenou8,9, Richard Delorme8,10,11, Myriam Ly-Le Moal12, Marion Leboyer13,8,11, Manuel Bouvard4,8,14, Jean-René Cazalets4.
Abstract
BACKGROUND: Inhibitory control and attention processing atypicalities are implicated in various diseases, including autism spectrum disorders (ASD). These cognitive functions can be tested by using visually guided saccade-based paradigms in children, adolescents and adults to determine the time course of such disorders.Entities:
Keywords: Antisaccade task; Attention shifting; Autism spectrum disorders (ASD); Eye-tracking; Gap–Overlap–Step tasks; Inhibitory control; Oculomotor behavior
Mesh:
Year: 2021 PMID: 34774105 PMCID: PMC8590241 DOI: 10.1186/s13229-021-00474-2
Source DB: PubMed Journal: Mol Autism Impact factor: 7.509
Fig. 1Experimental design. From left to right: Gap, Step, Overlap and Antisaccade tasks. As indicated by the white arrows (in lower panels), in the first three tasks, after an initial center screen fixation (green boxes), participants had to move their gaze toward a peripheral target (red squares) as soon as it appeared on the screen. The central anchoring point (green square) disappeared prior to (Gap task) or coincident with (Step task, i.e., 0-Gap) the peripheral target’s appearance, or it remained on screen along with target in the Overlap task. In the Antisaccade task, participants had to move their eyes in the opposite direction to that of the target. The Gap, Step and Overlap tasks allow the evaluation of attention disengagement by means of the Gap (Gap latency < Step latency) and Overlap effects (Step latency < Overlap latency). The Antisaccade task allows assessment of inhibitory control (Gap latency < Antisaccade latency)
Participant profiles at study onset (time point T0)
| AGE | Full IQ | ADHD Prevalence | ADOS_TOT_CS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ASD | TD | ASD | TD | ASD | TD | ASD | TD | ASD | |
| Adults ( | 35 M:25 F:10 | 29 M:21 F:8 | 29 ± 6.9 M:28.5 ± 7.1 F:30.4 ± 5.7 | 29.3 ± 6.7 M: 29.1 ± 6.9 F: 30.2 ± 5.4) | 109.1 ± 16 M: 107.5 ± 16.9 F: 113.3 ± 14.1 | 106.6 ± 13.8 M: 109.1 ± 2.6 F: 97.2 ± 12.2 | 5 (4 M, 1 F) 15% | 0 | 11.1 ± 2.4 |
| Teenagers ( | 29 M:24 F:5 | 11 M:7 F:4 | 14.1 ± 1.3 M: 14 ± 1.2 F: 15 ± 1 | 13.9 ± 1.2 M: 14.2 ± 1.1 F: 13.5 ± 1.3 | 103.1 ± 13.6 M: 101 ± 12.6 F: 126 ± 4 | 108.6 ± 11.7 M: 111.8 ± 9.4 F: 104.5 ± 13 | 11 (11 M, 0 F) 48% | 0 | 12.1 ± 0.5 |
| Children ( | 33 M:31 F:2 | 9 M:6 F:3 | 8.8 ± 1.4 M: 8.8 ± 1.4 F: 8.5 ± 1.5 | 7.9 ± 1.53 M: 7.3 ± 1.1 F: 8.6 ± 1.7 | 96.7 ± 15 M: 97.9 ± 15.2 F: 83 ± 6 | 103.8 ± 14 M: 104.5 ± 16.3 F: 103 ± 11.2 | 13 (12 M, 1 F) 52% | 0 | 11.7 ± 0.7 |
| Total (All) ( | 97 M: 80 F: 17 | 49 M: 34 F: 11 | 18.6 ± 8.6 M: 17.5 ± 8 F: 24.9 ± 9.4 | 21.2 ± 9.55 M: 22.5 ± 9.1 F: 18.5 ± 9.3 | 103.6 ± 15.9 M: 102.3 ± 15.6 F: 110.6 ± 16.2 | 106.3 ± 13.4 M: 108.8 ± 12.7 F: 101.1 ± 13 | 29 (27 M, 2 F) 36% | 0 | 11.6 ± 1.5 |
Mean values ± SD
IQ, Intelligence Quotient; ASD, Autism Spectrum disorders; F, Females; M, Males; TD, Typical Development; and ADHD, Attention Deficit with or without Hyperactivity Disorders
ADHD-RS and BRIEF subscores
| ALL TD | ALL ASD | CHILDREN | TEENAGERS | ADULTS | ||||
|---|---|---|---|---|---|---|---|---|
| TD | ASD | TD | ASD | TD | ASD | |||
| ADHD-RS_Total SCORE | 6.90 ± 1.01 | 23.47 ± 1.45 | 8.29 ± 1.97 | 31.33 ± 2.67 | 6.80 ± 1.52 | 20.48 ± 2.41 | 6.13 ± 1.57 | 20.11 ± 1.99 |
| ADHD-RS-SCORE1 (Inattention Score) | 3.6 ± 0.65 | 15.01 ± 0.96 | 3.57 ± 1.02 | 19.10 ± 1.7 | 5.00 ± 1.36 | 14.72 ± 1.72 | 3.04 ± 1.0112 | 12.21 ± 1.37 |
| ADHD-RS-SCORE2 (Hyperactivity Score) | 3.29 ± 0.63 | 9.8 ± 0.84 | 4.71 ± 1.58 | 14.43 ± 1.81 | 1.80 ± 0.63 | 7.76 ± 1.25 | 3.93 ± 0.81 | 8.14 ± 1.07 |
| BRIEF-GEC (Total Score) | 86.8 ± 2.68 | 145.35 ± 3.67 | 99.00 ± 6.36 | 162.05 ± 4.51 | 91.11 ± 5.51 | 143.25 ± 7.14 | 77.67 ± 1.76 | 134.77 ± 5.84 |
| BRIEF-BRI (Behavioral Regulation Index) | 33.71 ± 0.88 | 56.89 ± 1.64 | 36.93 ± 2.48 | 59 ± 2.45 | 33.2 ± 1.52 | 53.3 ± 3.16 | 32.04 ± 0.58 | 5812 ± 2.76 |
| BRIEF-MI (Metacognition Index) | 52.79 ± 1.96 | 88.46 ± 2.54 | 62.07 ± 4.2 | 103.05 ± 2.96 | 57.44 ± 4.4 | 89.95 ± 4.49 | 45.63 ± 1.37 | 76.65 ± 3.59 |
Mean values ± sem
Oculomotor variables description
| Dependent variable name | Description |
|---|---|
| Latency (ms) | The delay between the onset of the peripheral target and the first non-anticipatory fixation. This variable is used to asses Gap and Overlap effects |
| Anticipatory saccade (%) | Percentage of trials where saccadic movements occurred within 100 ms following target presentation |
| Erroneous saccade (%) | Percentage of trials where the first non-anticipatory saccade (> 100 ms) was in the wrong direction as requested by the instructions |
| Gain to first fixation | The ratio between the actual distance travelled during the first saccade and the theoretical distance required to reach the target |
Fig. 2Gap and Overlap task effects. A Plots of mean latency values in the three tasks (All participants, N = 146). Note the progressive significant increase in latency from Gap to Overlap task. B Gap (B1) and Overlap (B2) effects assessed by computing the differences in latency between Step and Gap tasks and between Overlap and Step tasks. A Adults (N = 64); C children (N = 42); T: teenagers (N = 40). C Plots of mean coefficient of variation (COV) of latency values in the three tasks (All participants, N = 146). Bars indicate the standard error of the mean; *p < 0.05
Fig. 3Anticipatory saccade. Plots of mean percentage of anticipatory saccades performed in the three tasks. ASD participants made significantly more anticipatory saccades than their TD peers in the three tasks. Bars indicate the standard error of the mean; *p < 0.05
Fig. 4Analysis of accuracy in Gap, Step and Overlap tasks. A Plots of mean gain values. There was a significant difference in gain to first fixation between ASD and TD participants (A1), in the course of development (A2) and between tasks (A3). B Plots of mean coefficient of variation of gain values. While there were no significant differences between ASD and TD participants, there was a significant developmental improvement between age groups (B2), and between tasks. Bars indicate the standard error of the mean; *p < 0.05
Fig. 5Antisaccade task effects. A Plots of mean differences in latency between Gap and Antisaccade tasks indicating significant differences between clinical groups for children and teenagers. B Plots of mean gain values indicate significant differences between age groups and significant differences in accuracy in the Gap task versus Antisaccade task for ASD participants. C ASD participants performed more erroneous saccades in the Antisaccade task compared to Gap task and more than TD participants in the Antisaccade task (C1). The percentage of erroneous saccades decreased over development (C2). D Plots of mean coefficient of variation of latency (D1)/gain (D2) indicating significant differences between the two tasks. Bars indicate the standard error of the mean; *p < 0.05
Fig. 6Correlations between oculomotor variables and clinical measures. A Correlation plots were drawn for ASD participants between ADHD-RS total score and delta Overlap–Gap, erroneous saccade percentage and gain (averaged values from all trials in prosaccade tasks. B Correlation plots were drawn for all participants between BRIEF-GEC and delta Overlap–Gap, erroneous saccade percentage and gain (averaged values from all trials in prosaccade tasks). Bars indicate the standard error of the mean; *p < 0.05
Fig. 7Analysis of changes in oculomotor variables over 2 years of follow-up. A Plots of mean latency difference values to assess changes in Gap and Overlap effects over 2 years. B Plots of mean gain values over 2 years. T0: Study onset; Y1: year 1; Y2: year 2. Bars indicate the standard error of the mean; *p < 0.05